Description

• • Thymosin Alpha 1 (TA1) (10mg) is a synthetic peptide fragment derived from prothymosin alpha, intended solely for laboratory research use and studied for its role in immunological signaling pathways.
  • Research has examined TA1 in preclinical models for its influence on T-cell activity and the regulation of cytokine expression within controlled experimental conditions.
  • This peptide has been evaluated for its potential involvement in modulating inflammatory responses and immune-related cellular signaling in non-clinical studies.
  • TA1 is often used in laboratory investigations exploring immune response dynamics in the context of age-related models and immune system variability.
  • Ongoing research explores TA1 within experimental frameworks related to host-cell interactions, immune pathway regulation, and peptide-driven studies of immunobiology.